Workflow
四环生物:2024年报净利润-1.1亿 同比下降46.67%

Financial Performance - The company reported a basic earnings per share of -0.1068 yuan for 2024, a decrease of 46.1% compared to -0.0731 yuan in 2023 [1] - The net profit for 2024 was -1.1 billion yuan, representing a 46.67% decline from -0.75 billion yuan in 2023 [1] - The return on equity (ROE) fell to -25.72% in 2024, down 77.5% from -14.49% in 2023 [1] - Operating revenue decreased to 2.04 billion yuan, a 13.19% drop from 2.35 billion yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 42.66 million shares, accounting for 41.44% of the circulating shares, a decrease of 1.31 million shares from the previous period [2] - Wang Hongming remains the largest shareholder with 14.14 million shares, unchanged from the previous report [3] - Yu Qinfeng's holdings decreased by 1.5 million shares to 13.24 million shares, representing 12.86% of total shares [3] - New entrants to the top ten shareholders include Chen Zhong with 0.448 million shares and Lou Xiaofeng with 0.367 million shares [3] Dividend Policy - The company has announced no distribution or capital increase for the current period [2]